Mohammad Muhsin Chisti

7PUBLICATIONS
8CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 22, 2025
SGLT2 inhibitors and cardiovascular outcomes in patients with multiple myeloma and concomitant type 2 diabetes mellitus.

Jia Yi Tan, Aravinthan Vignarajah, Yong Hao Yeo

|Dec 28, 2023
Mortality trends of chronic lymphocytic leukaemia in the United States with the emergence of targeted therapy.

Jia Yi Tan, Yong-Hao Yeo, Min Choon Tan

|Jun 24, 2022
Use of circulating tumour DNA in nasopharyngeal carcinoma to detect minimal residual disease.

Bipin Ghimire, Emma Herrman, Ujjwal Karki

|Mar 25, 2022
Thrombotic thrombocytopenic purpura following administration of the Moderna booster vaccine.

Emma Herrman, Bipin Ghimire, Mohammad Muhsin Chisti

|Jun 26, 2021
Adult Xp11.2 translocation renal cell carcinoma managed effectively with pazopanib.

Cristian Solano, Shrinjaya Thapa, Mohammad Muhsin Chisti

|Apr 22, 2019
MDS with 5q deletion and rare cKIT positive mastocytosis: a diagnostic and therapeutic challenge.

Daniel Steven Sanders, Thomas Fennell, Mohammad Muhsin Chisti

Pageof 2